Brain positron emission tomography in splenectomized adults with β-thalassemia intermedia: Uncovering yet another covert abnormality

Annals of Hematology

Volumn 91, Issue 2, 2012, Pages 235-241

  Musallam, Khaled M ^a   Nasreddine, Wassim ^b   Beydoun, Ahmad ^a   Hourani, Roula ^a   Hankir, Ahmed ^a   Koussa, Suzanne ^c   Haidar, Mohamad ^d   Taher, Ali T ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b RAFIC HARIRI UNIVERSITY HOSPITAL   (Lebanon)

^c Chronic Care Center Hazmieh   (Lebanon)

^d MOUNT LEBANON HOSPITAL   (Lebanon)

Author keywords

Brain; Iron overload; PET; Splenectomy; Thalassemia intermedia

Indexed keywords

FERRITIN; FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; BETA THALASSEMIA; BRAIN DISEASE; BRAIN FUNCTION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRY WEIGHT; FEMALE; FRONTAL LOBE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; IRON OVERLOAD; LIVER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEX RATIO; SPLENECTOMY; TEMPORAL LOBE;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BRAIN INFARCTION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IRON OVERLOAD; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSPECTIVE STUDIES; RISK FACTORS; SPLENECTOMY;

EID: 84857366913     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-011-1291-3     Document Type: Article

References (43)

1. AT Taher KM Musallam MD Cappellini DJ Weatherall 2011 Optimal management of β thalassaemia intermedia Br J Haematol 152 512 523 21250971 10.1111/j.1365-2141.2010.08486.x 1:CAS:528:DC%2BC3MXksFWrt7s%3D
2. Steinberg MH, Forget BG, Higgs DR, Weatherall DJ (2009) Disorders of hemoglobin: genetics pathophysiology, and clinical management, 2nd edn. Cambridge University Press, Cambridge
3. MD Cappellini I Motta KM Musallam AT Taher 2010 Redefining thalassemia as a hypercoagulable state Ann N Y Acad Sci 1202 231 236 20712798 10.1111/j.1749-6632.2010.05548.x 1:CAS:528:DC%2BC3cXhtFGmsL7P
4. AT Taher KM Musallam A El-Beshlawy M Karimi S Daar K Belhoul MS Saned G Graziadei MD Cappellini 2010 Age-related complications in treatment-naive patients with thalassaemia intermedia Br J Haematol 150 486 489 20456362
5. AT Taher KM Musallam M Karimi A El-Beshlawy K Belhoul S Daar MS Saned AH El-Chafic MR Fasulo MD Cappellini 2010 Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study Blood 115 1886 1892 20032507 10.1182/blood-2009-09-243154 1:CAS:528:DC%2BC3cXhtFensbnI
6. A Taher H Isma'eel G Mehio D Bignamini A Kattamis EA Rachmilewitz MD Cappellini 2006 Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran Thromb Haemost 96 488 491 17003927 1:CAS:528:DC%2BD28Xht1GrtL3N (Pubitemid 44560684)
7. MD Cappellini L Robbiolo BM Bottasso R Coppola G Fiorelli AP Mannucci 2000 Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia Br J Haematol 111 467 473 11122086 10.1046/j.1365-2141.2000.02376.x 1:STN:280:DC%2BD3M7hs1GqtQ%3D%3D (Pubitemid 32009338)
8. AT Taher KM Musallam M Karimi A El-Beshlawy K Belhoul S Daar M Saned C Cesaretti MD Cappellini 2010 Splenectomy and thrombosis: the case of thalassemia intermedia J Thromb Haemost 8 2152 2158 20546125 10.1111/j.1538-7836.2010. 03940.x 1:STN:280:DC%2BC3cbktVKktQ%3D%3D
9. V Atichartakarn P Angchaisuksiri K Aryurachai S Onpun S Chuncharunee A Thakkinstian K Atamasirikul 2002 Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/beta-thalassaemic patients Br J Haematol 118 893 898 12181063 10.1046/j.1365-2141.2002.03711.x 1:CAS:528:DC%2BD38Xos1CjurY%3D (Pubitemid 35007399)
10. D Rund E Rachmilewitz 2005 Beta-thalassemia N Engl J Med 353 1135 1146 16162884 10.1056/NEJMra050436 1:CAS:528:DC%2BD2MXhtVWhsbnL (Pubitemid 41317436)
11. L Manfre E Giarratano A Maggio A Banco G Vaccaro R Lagalla 1999 MR imaging of the brain: findings in asymptomatic patients with thalassemia intermedia and sickle cell-thalassemia disease AJR Am J Roentgenol 173 1477 1480 10584785 1:STN:280:DC%2BD3c%2FkvFCrsg%3D%3D
12. AT Taher KM Musallam W Nasreddine R Hourani A Inati A Beydoun 2010 Asymptomatic brain magnetic resonance imaging abnormalities in splenectomized adults with thalassemia intermedia J Thromb Haemost 8 54 59 19817994 10.1111/j.1538-7836.2009.03651.x 1:STN:280:DC%2BC3c7hs1aqsw%3D%3D
13. C Camaschella MD Cappellini 1995 Thalassemia intermedia Haematologica 80 58 68 7758995 1:STN:280:DyaK2M3nvVyjug%3D%3D
14. TG St Pierre PR Clark W Chua-anusorn AJ Fleming GP Jeffrey JK Olynyk P Pootrakul E Robins R Lindeman 2005 Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance Blood 105 855 861 15256427 10.1182/blood-2004-01-0177 1:CAS:528:DC%2BD2MXltlGmuw%3D%3D (Pubitemid 40070775)
15. Afifi AA, Clark V, May S (2004) Computer-aided multivariate analysis, 4th edn. Chapman & Hall/CRC, New York, p 489
16. A Taher C Hershko MD Cappellini 2009 Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies Br J Haematol 147 634 640 19681884 10.1111/j.1365-2141.2009.07848.x 1:CAS:528:DC%2BD1MXhs1SjtL7J
17. A Taher F El Rassi H Isma'eel S Koussa A Inati MD Cappellini 2008 Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia Haematologica 93 1584 1586 18728025 10.3324/haematol.13098 1:CAS:528: DC%2BD1cXhtl2gur3F
18. A Roghi MD Cappellini JC Wood KM Musallam P Patrizia MR Fasulo C Cesaretti AT Taher 2010 Absence of cardiac siderosis despite hepatic iron overload in Italian patients with thalassemia intermedia: an MRI T2*study Ann Hematol 89 585 589 20016898 10.1007/s00277-009-0879-3 1:CAS:528: DC%2BC3cXkvVCqu74%3D
19. AT Taher KM Musallam JC Wood MD Cappellini 2010 Magnetic resonance evaluation of hepatic and myocardial iron deposition in transfusion-independent thalassemia intermedia compared to regularly transfused thalassemia major patients Am J Hematol 85 288 290 20143405 10.1002/ajh.21626 1:CAS:528: DC%2BC3cXls12ltbc%3D
20. R Origa S Barella GM Argiolas P Bina A Agus R Galanello 2008 No evidence of cardiac iron in 20 never- or minimally-transfused patients with thalassemia intermedia Haematologica 93 1095 1096 18508795 10.3324/haematol.12484 (Pubitemid 351957030)
21. X Li J Jankovic W Le 2011 Iron chelation and neuroprotection in neurodegenerative diseases J Neural Transm 118 473 477 21161300 10.1007/s00702-010-0518-0 1:CAS:528:DC%2BC3MXjsFyqtro%3D
22. LA Verduzco DG Nathan 2009 Sickle cell disease and stroke Blood 114 5117 5125 19797523 10.1182/blood-2009-05-220921 1:CAS:528:DC%2BC3cXls1arsg%3D%3D
23. GP Rodgers CM Clark SM Larson SI Rapoport AW Nienhuis AN Schechter 1988 Brain glucose metabolism in neurologically normal patients with sickle cell disease. Regional alterations Arch Neurol 45 78 82 3257387 10.1001/archneur. 1988.00520250084025 1:STN:280:DyaL1c7gs1Smtw%3D%3D (Pubitemid 18018591)
24. DR Powars PS Conti WY Wong P Groncy C Hyman E Smith N Ewing RN Keenan CS Zee Y Harold AL Hiti EL Teng LS Chan 1999 Cerebral vasculopathy in sickle cell anemia: diagnostic contribution of positron emission tomography Blood 93 71 79 9864148 1:STN:280:DyaK1M%2FotFKjtg%3D%3D (Pubitemid 29019390)
25. S Herold M Brozovic J Gibbs AA Lammertsma KL Leenders D Carr JS Fleming T Jones 1986 Measurement of regional cerebral blood flow, blood volume and oxygen metabolism in patients with sickle cell disease using positron emission tomography Stroke 17 692 698 3488606 10.1161/01.STR.17.4.692 1:STN:280:DyaL283ptVGjuw%3D%3D (Pubitemid 16066541)
26. C Labbe JC Froment A Kennedy J Ashburner L Cinotti 1996 Positron emission tomography metabolic data corrected for cortical atrophy using magnetic resonance imaging Alzheimer Dis Assoc Disord 10 141 170 8876777 10.1097/00002093-199601030-00005 1:STN:280:DyaK2s%2FjtVygtA%3D%3D (Pubitemid 26306100)
27. RC Mehta MP Marks 1992 Physiologic imaging of the brain Curr Opin Radiol 4 95 100 1739606 1:STN:280:DyaK387ltlKltw%3D%3D
28. W Reed W Jagust M Al-Mateen E Vichinsky 1999 Role of positron emission tomography in determining the extent of CNS ischemia in patients with sickle cell disease Am J Hematol 60 268 272 10203099 10.1002/(SICI)1096-8652(199904)60: 4<268::AID-AJH3>3.0.CO;2-C 1:STN:280:DyaK1M3hslOnuw%3D%3D (Pubitemid 29160085)
29. H Gross A Kling G Henry C Herndon H Lavretsky 1996 Local cerebral glucose metabolism in patients with long-term behavioral and cognitive deficits following mild traumatic brain injury J Neuropsychiatry Clin Neurosci 8 324 334 8854305 1:STN:280:DyaK2s%2FgslSgsg%3D%3D (Pubitemid 26275745)
30. CH Pegelow EA Macklin FG Moser WC Wang JA Bello ST Miller EP Vichinsky MR DeBaun L Guarini RA Zimmerman DP Younkin DM Gallagher TR Kinney 2002 Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease Blood 99 3014 3018 11929794 10.1182/blood.V99.8.3014 1:CAS:528:DC%2BD38XivV2jsL4%3D (Pubitemid 34525393)
31. CH Pegelow W Wang S Granger LL Hsu E Vichinsky FG Moser J Bello RA Zimmerman RJ Adams D Brambilla 2001 Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity Arch Neurol 58 2017 2021 11735775 10.1001/archneur.58.12.2017 1:STN:280:DC%2BD38%2FivVyrtg%3D%3D (Pubitemid 33143980)
32. JA Switzer DC Hess FT Nichols RJ Adams 2006 Pathophysiology and treatment of stroke in sickle-cell disease: present and future Lancet Neurol 5 501 512 16713922 10.1016/S1474-4422(06)70469-0
33. JM Hoffman KA Welsh-Bohmer M Hanson B Crain C Hulette N Earl RE Coleman 2000 FDG PET imaging in patients with pathologically verified dementia J Nucl Med 41 1920 1928 11079505 1:STN:280:DC%2BD3M%2FktFOktA%3D%3D
34. MA Smith PL Harris LM Sayre G Perry 1997 Iron accumulation in Alzheimer disease is a source of redox-generated free radicals Proc Natl Acad Sci USA 94 9866 9868 9275217 10.1073/pnas.94.18.9866 1:CAS:528:DyaK2sXlvVWjsLo%3D (Pubitemid 27408156)
35. PF Good DP Perl LM Bierer J Schmeidler 1992 Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study Ann Neurol 31 286 292 1637136 10.1002/ana.410310310 1:STN:280:DyaK38zksVentA%3D%3D
36. ST Miller EA Macklin CH Pegelow TR Kinney LA Sleeper JA Bello LD DeWitt DM Gallagher L Guarini FG Moser K Ohene-Frempong N Sanchez EP Vichinsky WC Wang DL Wethers DP Younkin RA Zimmerman MR DeBaun 2001 Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease J Pediatr 139 385 390 11562618 10.1067/mpd.2001.117580 1:STN:280:DC%2BD3MrktFyhsw%3D%3D (Pubitemid 32889515)
37. W Wang L Enos D Gallagher R Thompson L Guarini E Vichinsky E Wright R Zimmerman FD Armstrong 2001 Neuropsychologic performance in school-aged children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease J Pediatr 139 391 397 11562619 10.1067/mpd.2001.116935 1:STN:280:DC%2BD3MrktFyhsA%3D%3D (Pubitemid 32889516)
38. FD Armstrong RJ Thompson Jr W Wang R Zimmerman CH Pegelow S Miller F Moser J Bello A Hurtig K Vass 1996 Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease Pediatrics 97 864 870 8657528 1:STN:280:DyaK283jsl2ltQ%3D%3D (Pubitemid 26170948)
39. F Bernaudin S Verlhac F Freard F Roudot-Thoraval M Benkerrou I Thuret R Mardini JP Vannier E Ploix M Romero C Casse-Perrot M Helly E Gillard G Sebag H Kchouk JP Pracros B Finck JN Dacher V Ickowicz C Raybaud M Poncet E Lesprit PH Reinert P Brugieres 2000 Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation J Child Neurol 15 333 343 10830200 10.1177/088307380001500510 1:STN:280:DC%2BD3cvitFalsQ%3D%3D (Pubitemid 30341365)
40. S Kugler B Anderson D Cross Z Sharif M Sano R Haggerty I Prohovnik A Hurlet-Jensen S Hilal JP Mohr, et al. 1993 Abnormal cranial magnetic resonance imaging scans in sickle-cell disease. Neurological correlates and clinical implications Arch Neurol 50 629 635 8503800 10.1001/archneur.1993.00540060059019 1:STN:280:DyaK3s3nslCjsg%3D%3D (Pubitemid 23165593)
41. EP Vichinsky LD Neumayr JI Gold MW Weiner RR Rule D Truran J Kasten B Eggleston K Kesler L McMahon EP Orringer T Harrington K Kalinyak LM De Castro A Kutlar CJ Rutherford C Johnson JD Bessman LB Jordan FD Armstrong 2010 Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia JAMA 303 1823 1831 20460621 10.1001/jama.2010.562
42. J De Reuck D Leys J De Keyser 1997 Is positron emission tomography useful in stroke? Acta Neurol Belg 97 168 171 9345587 (Pubitemid 127514838)
43. M Arkuszewski ER Melhem J Krejza 2010 Neuroimaging in assessment of risk of stroke in children with sickle cell disease Adv Med Sci 55 115 129 21109500 10.2478/v10039-010-0045-0 1:STN:280:DC%2BC3M%2FltFCrsQ%3D%3D